Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 10, 2022

SELL
$126.46 - $235.05 $145,429 - $270,307
-1,150 Closed
0 $0
Q4 2021

Feb 25, 2022

BUY
$225.82 - $368.51 $259,693 - $423,786
1,150 New
1,150 $292,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $21.3B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Grant Street Asset Management, Inc. Portfolio

Follow Grant Street Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grant Street Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Grant Street Asset Management, Inc. with notifications on news.